Abstract:It has been previously reported that appropriately substituted 4-anilinoquinoline-3-carbonitriles are potent inhibitors of Src kinase, with biological activity in vitro and in vivo. Structural modifications to these compounds have been explored, providing the 4-anilinobenzo[g] quinoline-3-carbonitriles as a series with enhanced Src inhibitory properties. The synthesis and structure-activity relationships of these 4-anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles are presented here. Analogues with cyclic basic amine groups attached via ethoxy linkages at the C-8 position were the most active in vitro, with subnanomolar IC50 values against Src kinase observed for a majority of the compounds synthesized. Compound 17d was more potent in vitro than the analogously substituted 4-anilinoquinoline-3-carbonitrile SKI-606, which is undergoing evaluation in clinical trials. The most potent analogue synthesized was 17a, with an IC50 of 0.15 nM against Src kinase and with an IC50 of 10 nM against Src-transformed fibroblasts. Molecular modeling studies provided a rationale for the exceptional activity observed for these compounds, with favorable van der Waals interactions playing the major role. Compound 17c was found to be highly selective for Src kinase when tested against a panel of other kinases, with modest selectivity versus the Src family kinases Lyn and Fyn. Following ip dosing at 50 mg/kg, analogues 17c and 17d were shown to have plasma levels that significantly exceeded the cellular IC50 values against Src-transformed fibroblasts. In an Src-transformed fibroblast xenograft model, both compounds exhibited a significant inhibition of tumor growth.

Regioselective Synthesis of A Potent Src Kinase Inhibitor: 4-(2,4-dichloro-5-methoxyphenylamino)-7-methoxy-8-(2-morpholin-4-ylethox Y)Benzo[G]Quinoline-3-Carbonitrile

Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles.

4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.

Synthesis and Neuroprotective Biological Evaluation of Quinazolinone Derivatives Via Scaffold Hopping.

Optimization of 4-Phenylamino-3-quinolinecarbonitriles As Potent Inhibitors of Src Kinase Activity

Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities

7-(Aryl/heteroaryl-2-ylethynyl)-4-phenylamino-3-quinolinecarbonitriles As New Src Kinase Inhibitors: Addition of Water Solubilizing Groups.

7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles As Dual Inhibitors of Src and Abl Kinases

Groebke Multicomponent Reaction and Subsequent Nucleophilic Aromatic Substitution for a Convenient Synthesis of 3,8-Diaminoimidazo[1,2-a]pyrazines As Potential Kinase Inhibitors.

Regioselective Syntheses of 2,3,5-Trisubstituted Pyridines via 5-Chloro-3-fluoro-2-(methylsulfonyl)pyridine

Regioselective Access to 3-Aryl-1-aminoisoquinolines Via Nickel(I)Catalyzed C-C and C-N Cascade Coupling Reactions from the Substituted 2-(Cyanomethyl)benzonitriles

Design, Synthesis, and Evaluation of Substituted 6-Amide-4-anilinoquinazoline Derivatives As C-Src Inhibitors

Electrophilic Sulfenylation/Cyclization of Nâ€�Aryl and Nâ€�Benzyl Propynamides: Synthesis of Sulfenyl Quinolinones and 3Hâ€�Benzo[c]azepinâ€�3â€�ones

Dimethyl Sulfoxide-Assisted, Iodine- and Ascorbic Acid-Catalyzed One-Pot Synthetic Approach for Constructing Highly Substituted Pyrazolo[1,5- a]quinoline Thioether Derivatives

High-yielding regioselective synthesis of p -quinone fused 5-substituted-1,4-benzodiazepine scaffolds via Pictet–Spengler type cycloannulation

6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: a new scaffold endowed with potent CDK2 inhibitory activity

Benzo[6,7]cyclohepta[1,2- d ]pyrazolo[1,5- a ]pyrimidines: Regioselective synthesis of a Novel Ring System, DFT-based NMR prediction, local reactivity indexes, and MEP analysis

Design, Modification and 3D QSAR Studies of Novel 2,3-Dihydrobenzo[b][1,4]dioxin-containing 4,5-Dihydro-1h-pyrazole Derivatives As Inhibitors of B-Raf Kinase.

Synthesis, Characterization, Screening And Docking Analysis Of 4-Anilinoquinazoline Derivatives As Tyrosine Kinase Inhibitors

Catalytic Enantioselective Formal Synthesis of MDM2 Antagonist RG7388 and Its Analogues

A Regioselective Synthesis of 7-Methyl Juglone and Its Derivatives.